Helmerich & Payne, Inc.HPNYSE
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
13 analysts·Moderate coverage
38%
Rating Distribution
Strong Buy
00%
Buy
538%
Hold
538%
Sell
323%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 0% above analyst consensus — near fair value expected.

Bear Case
$26.00
-20%
Consensus
$32.29
-0%
Bull Case
$36.00
+11%
Price Range13 analysts
Low
Consensus
High
$26.00
$36.00
Current Target
Current Price
$32.38
Above Target
$0.09

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 15, 2026RBC Capital
Helmerich & Payne price target raised to $34 from $29 at RBC Capital
Target:$34.00
+6.5%from $31.92
Jan 14, 2026Goldman Sachs
Helmerich & Payne price target raised to $32 from $28 at Goldman Sachs
Target:$32.00
+2.3%from $31.27
Jan 7, 2026Susquehanna
Helmerich & Payne price target raised to $36 from $31 at Susquehanna
Target:$36.00
+17.9%from $30.54
Dec 18, 2025Piper Sandler
Helmerich & Payne upgraded to Overweight from Neutral at Piper Sandler
Target:$35.00
+25.0%from $28.01
Dec 17, 2025Barclays
Helmerich & Payne price target raised to $36 from $9 at Barclays
Target:$36.00
+31.7%from $27.34
Dec 15, 2025Morgan Stanley
Helmerich & Payne assumed with an Underweight at Morgan Stanley
Target:$26.00
-9.3%from $28.68
Nov 25, 2025Morgan Stanley
Helmerich & Payne price target raised to $23 from $20 at Morgan Stanley
Target:$23.00
-13.5%from $26.58
Nov 20, 2025Goldman Sachs
Helmerich & Payne upgraded to Neutral from Sell at Goldman Sachs
Target:$28.00
+7.3%from $26.10
Nov 20, 2025RBC Capital
Helmerich & Payne price target raised to $29 from $27 at RBC Capital
Target:$29.00
+4.5%from $27.74
Nov 20, 2025Barclays
Helmerich & Payne price target raised to $29 from $25 at Barclays
Target:$29.00
+6.6%from $27.20
Nov 19, 2025Evercore ISI
Helmerich & Payne (HP) PT Raised to $27 at Evercore ISI
Target:$27.00
+1.7%from $26.56
Sep 22, 2025Barclays
Helmerich & Payne upgraded to Overweight from Equal Weight at Barclays
Target:$25.00
+21.7%from $20.54
Jul 26, 2024RBC Capital
Helmerich & Payne price target raised to $50 from $48 at RBC Capital
Target:$50.00
+20.8%from $41.40
Jul 25, 2024CFRA
CFRA Upgrades Helmerich & Payne (HP) to Buy
Target:$47.00
+15.8%from $40.57
May 6, 2024Piper Sandler
Helmerich & Payne (HP) PT Lowered to $39 at Piper Sandler
Target:$39.00
+1.4%from $38.47
Feb 1, 2023Susquehanna
Susquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $72
Target:$72.00
+59.6%from $45.12
Nov 21, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Helmerich & Payne, Raises Price Target to $60
Target:$60.00
+17.5%from $51.05
Nov 18, 2022Susquehanna
Helmerich & Payne price target raised to $65 from $62 at Susquehanna
Target:$65.00
+24.9%from $52.06
Aug 1, 2022Morgan Stanley
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $48
Target:$48.00
+7.2%from $44.77
Aug 1, 2022Barclays
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $58
Target:$58.00
+25.3%from $46.30
Jul 13, 2022Morgan Stanley
Morgan Stanley Maintains Underweight on Helmerich & Payne, Lowers Price Target to $45
Target:$45.00
+15.3%from $39.04
Jul 13, 2022Goldman Sachs
Goldman Sachs Maintains Sell on Helmerich & Payne, Lowers Price Target to $38
Target:$38.00
-2.8%from $39.10
Jul 6, 2022Citigroup
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $49
Target:$49.00
+21.7%from $40.25
Jun 17, 2022Susquehanna
Helmerich & Payne (HP) Stock Price: $62 Target And Positive Rating
Target:$62.00
+59.5%from $38.86
Jun 7, 2022Piper Sandler
Helmerich & Payne (HP) Stock Price: $53 Target From Piper Sandler
Target:$53.00
+0.4%from $52.78